0001016504-08-000073 Sample Contracts

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS REGISTRATION RIGHTS AGREEMENT, dated as of October 14, 2008 (this “Agreement”), is by and between INTEGRATED BIOPHARMA, INC., a Delaware corporation (the “Company”), and each of the investors whose names appear on the signature pages hereof. Such investors are each referred to herein as an “Investor” and, collectively, as the “Investors”. The Company has agreed, on the terms and subject to the conditions set forth in the First Amendment to Amended and Restated Securities Purchase Agreement and 8% Senior Secured Notes, dated as of the date hereof (the “Amendment”), between the Company and the Investors, to issue to the Investors Warrants (the “Warrants”) exercisable for the Company’s Common Stock, par value $0.002 per share (the “Common Stock”).

AutoNDA by SimpleDocs
OF
Warrant • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

This Warrant has been issued pursuant to the First Amendment to Amended and Restated Securities Purchase Agreement and 7% Senior Secured Notes, dated as of the date hereof (the “Amendment”), by and between the Company, the Holder and the other investors party thereto. The Amendment amends, among other things, certain provisions of the Amended and Restated Securities Purchase Agreement, dated as of February 21, 2008 (the “Securities Purchase Agreement”), by and between the Company, the Hodler and the other investors party thereto.

AMENDED AND RESTATED FIRST AMENDMENT TO AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT AND 8% SENIOR SECURED NOTES
Securities Purchase Agreement • October 20th, 2008 • Integrated Biopharma Inc • Pharmaceutical preparations • New York

THIS AMENDED AND RESTATED FIRST AMENDMENT TO AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT AND 8% SENIOR SECURED NOTES, dated as of October 20, 2008 (this “Amendment”), is by and between Integrated BioPharma, Inc., a Delaware corporation (the “Company”), and each of the investors whose names appear on the signature pages hereof. Such investors are each referred to herein as an “Investor” and, collectively, as the “Investors”.

Time is Money Join Law Insider Premium to draft better contracts faster.